Connect with us

Health

Lifestores Healthcare Gets $3m to Offer More Services

Published

on

Lifestores Healthcare

By Adedapo Adesanya

To deepen healthcare offerings in the country, Lifestores Healthcare has closed a $3 million pre-series A funding round.

The oversubscribed round was led by Health54, the healthcare-focused corporate venture capital arm of CFAO Group, with Aruwa Capital Management as a supporting lead, along with participation from other existing investors.

Founded in 2017 by Mr Bryan Mezue, Mr Ken Ahaotu (a pharmacist), and Mr Andrew Garza, Lifestores Healthcare, a Nigerian healthtech company, originated as a chain of retail pharmacies before launching its OGApharmacy service in 2020.

With this investment, Lifestores will expand across Nigeria, improve its software capabilities, and reach new customer segments. It plans to do this by expanding its sales and engineering teams, as well as its senior management.

Lifestores operates an online Business-to-Business (B2B) pharmaceutical marketplace, OGApharmacy, which provides pharmacies with 10-20 per cent group discounts, cutting-edge supply chain software, and the confidence that medications are authentic and not dangerous counterfeits.

Experiencing a 25 per cent monthly marketplace growth to date, OGApharmacy says it counts more than 10 per cent of Nigeria’s pharmacies as registered customers.

Mr Andrew Garza, the company’s co-founder and Chief Operating Officer, said, “Our scope goes beyond merely distributing medicines and stabilizing prices. Essentially, pharma wholesalers are the ‘banks’ of the healthcare supply chain in Nigeria, and their impact on the overall economy is considerable. By optimizing how we extend credit to our healthcare provider partners and modernizing patient access to health financing, we are able to power the growth of our partners and increase patient access to quality care.”

Lifestores also aims to increase the number of OGApharmacy customers from 10 per cent to 25 per cent of Nigeria’s total market share, increasing the number of patients reached by 4x from 100,000 to 400,000 by 2023.

To drive growth, Lifestores will open a new Lagos processing centre and launch new technology features as part of its B2B offerings, including pharmacy management software, AI-driven predictive ordering, advanced credit offerings, and patient management initiatives.

Additionally, the startup will leverage CFAO Healthcare’s existing wholesale distribution capabilities in Nigeria and across Africa as well as Health54’s increasing network of health services innovators and providers.

It will also expand its  Business-to-Customers (B2C) services with pilots in patient savings, care management, and medication delivery.

“We are thrilled to have Health54 join our mission of democratizing access to quality and affordable primary healthcare in sub-Saharan Africa, together with existing investors, such as Aruwa Capital and the Lionbear consortium,” said Mr Bryan Mezue, Co-founder & CEO of Lifestores Healthcare.

“The vast majority of Africans will visit their local pharmacy for treatment. We aim to support pharmacists, the unsung heroes of African healthcare, with the critical services they need to procure and provide safe and affordable medications to their patients,” he said.

“We’re proud and happy to make our first investment with Health54 in Nigeria and in Lifestores. We were impressed with Bryan and Andrew’s on-the-ground experience of having run multiple retail pharmacies in Nigeria. In two years, they have built a first-rate distribution platform with OGAPharmacy. As a strategic partner, we’re delighted to work together and bring the benefits of our vertically integrated pharmaceutical supply chain, so we can support more patients in Nigeria and beyond with quality primary healthcare,” according to Mr Côme Vercken, Managing Director, Health54.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Click to comment

Leave a Reply

Health

DoorSpace Exits Meta Platforms Over Fact-checking System

Published

on

DoorSpace

By Aduragbemi Omiyale

A healthcare technology platform, DoorSpace, has announced its exit from all Meta platforms, citing value differences and company culture as reasons for the action.

Ahead of the inauguration of Mr Donald Trump as the President of the United States of America (USA) for a second term on tomorrow, Monday, January 20, 2025, Mr Mark Zuckerberg announced changes to his platforms’ fact-checking system.

“The only way that we can push back on this global trend is with the support of the US government, and that’s why it’s been so difficult over the past four years, when even the US government has pushed for censorship,” Mr Zuckerberg said in a video.

He said Meta was welcoming political discourse back on Facebook, Instagram and Threads with the new Community Notes system, which will enable users to write and rate notes that can be added onto posts.

Mr Zuckerberg explained that Meta would be working closely with Mr Trump’s upcoming administration by showing users more content that is politically charged and not checked by third-party fact checkers.

This decision of Meta did not go down well with DoorSpace, which said it has ceased any activity and would no longer spend marketing dollars to advertise on Meta platforms.

“Zuckerberg’s business decisions to rollback its fact checking system and to open up the platform to allow for misinformation, hate and bullying, especially against vulnerable minority groups, shows his lack of understanding on the importance of diversity and common decency.

“Incel culture will continue to grow and fester in that curated environment, leading to more violence against these groups in the real world,” the chief executive of DoorSpace, Ms Sarah M. Worthy, said.

“”I need to stand by my values and use my position as a healthcare tech leader to advocate for the individuals who are directly harmed in both their professional and personal lives by the hate and misinformation being spread on Zuckerberg’s platforms.

“The Meta that Zuckerberg has created has become a cesspool that sells its users’ data to the highest bidder while utilizing manipulative and dangerous tactics to keep people on the app as long as possible,” Ms Worthy added.

“Your data is not secure on their platforms, their algorithmic feed is designed to sow division and misinformation, and the company has announced that it does not view every American equally.

“There is no need for our business to spend money advertising there or any reason for our brand to maintain an active presence there anymore,” she said further.

Continue Reading

Health

Mums Feel Warmth Initiative Raises Postpartum Depression Awareness

Published

on

Mums Feel Warmth Postpartum Depression

By Modupe Gbadeyanka

A transformative webinar to raise awareness on postpartum depression (PPD) by nursing mothers has been organised by MSc Media and Communication students from the School of Media and Communications of the Pan-Atlantic University.

The programme titled Beyond Baby Blues: Understanding and Overcoming Postpartum Depression was held on January 7, 2025.

It was put together by the students under the Mums Feel Warmth initiative, with experts in the field invited to speak on the matter aimed at empowering mothers and fostering a sense of reassurance.

The webinar was to highlight the journey through postpartum depression, offering a message of hope, resilience, and the importance of mental health support for mothers everywhere.

One of the speakers, Dr Laja Odunuga, who is the Care Coordinator for AVON HMO, explained the difference between the common “baby blues” and the more severe, long-lasting PPD.

The discussion highlighted how PPD can manifest not just as sadness but through severe fatigue, disconnection from the newborn, and loss of interest in activities, which can last well beyond the typical two-week period associated with baby blues.

Another expert, Ms Otomfon Ibanga, the Assistant Lead Nurse for Q-Life Family Clinic, emphasised the role of support systems, urging families and friends to be vigilant for signs of PPD and to provide a nurturing environment.

She also discussed prevention strategies, including prenatal planning for support structures and post-delivery management through therapy or medication.

On his part, Dr Chimaraoke Obialo, who is the Medical Director of Life Amada Health Consultancy, addressed the stigma surrounding PPD, advocating for education to transform societal perceptions from judgement to support.

The webinar underscored the need for community involvement, not just in recognising symptoms but in actively participating in the healing process by offering emotional and practical support.

The Mums Feel Warmth webinar was more than just an educational session; it was a call to action for society to embrace and support new mothers dealing with PPD.

By fostering open conversations and providing platforms for sharing experiences, Mums Feel Warmth continues to lead the charge against the stigma of PPD.

The commitment shown by the panellists and attendees alike promises a future where every mother has access to the understanding and care needed to navigate through the complexities of postpartum depression, ensuring that the joy of motherhood is not overshadowed by mental health challenges.

Mums Feel Warmth, with its core values of empathy, compassion, hope, community, and education, speaks to the Sustainable Development Goal 3, advocating for good health and well-being.

The initiative is breaking the silence around PPD, a condition that can significantly impact new mothers in the critical period following childbirth.

Continue Reading

Health

NCDC Monitors HMPV Situation, Affirms Nigeria at Moderate Risk

Published

on

HMPV

By Adedapo Adesanya

The Nigeria Centre for Disease Control (NCDC) says the country is at “moderate” risk for Human Metapneumovirus (HMPV), a virus that leads to an upper respiratory tract infection with symptoms like cough, fever, and nasal congestion.

In a public health advisory, the Nigerian health agency said the federal government is closely monitoring the outbreak of the virus and is taking safety measures to “strengthen the country’s preparedness and response capacity”.

Recent reports indicate a significant rise in HMPV cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.

The NCDC said it conducted a risk assessment for the HMPV in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the US Centres for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA).

“The assessment classified the risk of HMPV for Nigeria as moderate. This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts,” the advisory said.

It said the NCDC is working to give Nigerians “timely, accurate information and guidance to keep the Nigerian public informed and prepared”.

NCDC noted that it “in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).

“These measures are designed to mitigate the potential risk of HMPV transmission through international travel.”

HMPV was first identified in the Netherlands in 2001 and the virus spreads through direct contact between people or when someone touches surfaces contaminated with it.

Children under two are most vulnerable to the virus alongside those with weakened immune systems such as the elderly and those with advanced cancer, according to medical experts.

There have also been worries that this could be like COVID-19, but experts have eased the fear as they are not similar because pandemics are typically caused by novel pathogens, which is not the case for HMPV.

Continue Reading

Trending